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ABSTRACT
Purpose: Following interventions against trachoma in Viet Nam, impact surveys conducted in
2003–2011 suggested that trachoma was no longer a public health problem. In 2014, we under-
took surveillance surveys to estimate prevalence of trachomatous inflammation—follicular (TF)
and trichiasis.
Methods: A population-based prevalence survey was undertaken in 11 evaluation units (EUs)
encompassing 24 districts, using Global Trachoma Mapping Project methods. A two-stage cluster
sampling design was used in each EU, whereby 20 clusters and 60 children per cluster were
sampled. Consenting eligible participants (children aged 1–9 years and adults aged ≥50 years)
were examined for trachoma.
Results: A total of 9391 households were surveyed, and 20,185 participants (98.8% of those
enumerated) were examined for trachoma. EU-level TF prevalence in 1–9-year-olds ranged from
0% to 1.6%. In one cluster (in Hà Giang Province), the percentage of children with TF was 10.3%.
The overall pattern of cluster-level percentages of children with TF, however, was consistent with
an exponential distribution, which would be consistent with trachoma disappearing. Among
people aged ≥50 years, prevalence of trichiasis by EU ranged from 0% to 0.75%; these estimates
are equivalent to 0–0.13% in all ages. The prevalence of trichiasis unknown to the health system
among people aged ≥50 years, by EU, ranged from 0% to 0.17%, which is equivalent to 0–0.03%
in all ages.
Conclusion: Findings suggest that trachoma is no longer a public health problem in any of the 11
EUs surveyed. However, given the high proportion of children with TF in one cluster in Hà Giang
Province, further investigations will be undertaken.
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Introduction
Trachoma is a neglected tropical disease that causes
blindness.1 In 2016, it was estimated that worldwide,
200 million people were at risk, and 3.2 million people
needed surgery to avoid trachomatous blindness, in 42
countries.2 According to criteria set by the World
Health Organization (WHO), trachoma is a public
health problem where the prevalence of trachomatous
inflammation—follicular (TF) is ≥5% in 1–9-year-olds,
and/or the prevalence of trachomatous trichiasis
unknown to the health system is ≥0.2% in ≥15-year-
olds (approximately equivalent to ≥0.1% in the all-ages
population).3 Global political commitment for elimina-
tion of trachoma as a public health problem was made
manifest by a 1998 World Health Assembly resolution;
the target date for achievement of this goal is December
2020.4,5
Viet Nam has been fighting trachoma for more
than 60 years. In 1950, the Ophthalmologic
Institute of Hanoi (which later became the Viet
Nam National Institute of Ophthalmology (VNIO))
estimated that more than 70% of the population on
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the outskirts of Hanoi suffered from active tra-
choma at some time during their lives.6 In 1951,
more than 200,000 people in North Viet Nam were
treated for trachoma by mobile teams.6 Following
sustained trachoma control efforts by the govern-
ment, the national prevalence had declined to 7% in
1995.7 With the 1996 launch of the WHO Alliance
for the Global Elimination of Trachoma by 2020
(GET2020), the government of Viet Nam and its
partners started implementing the “SAFE strategy”
against trachoma, i.e. surgery for trichiasis, antibio-
tics to clear infection with the causative organism
(Chlamydia trachomatis), and facial cleanliness and
environmental improvement to reduce transmission.8
In 2000–2001, 67 district-based surveys were under-
taken in 27 suspected-endemic provinces to identify
local needs for SAFE. After deployment of SAFE inter-
ventions, impact surveys were undertaken at four time
points: 2003, 2004, 2005, and 2009–2011. These sur-
veys suggested that trachoma was no longer a public
health problem, according to WHO criteria. However,
WHO’s standard operating procedures for validation
of elimination as a public health problem9 had not yet
been released. In 2014, given the need to complete a
second round of surveys to establish that recrudes-
cence of active trachoma had not occurred10, we
undertook a series of pre-validation trachoma surveil-
lance surveys in Viet Nam, aiming to estimate the
prevalence of trachomatous inflammation—follicular
(TF) in children aged 1–9 years and the prevalence of
trichiasis unknown to the health system in adults, in
previously trachoma-endemic districts.
Methods
We implemented population-based prevalence surveys
(PBPSs) using the systems and methods of the WHO-
recommended Global Trachoma Mapping Project
(GTMP), including version 2 of the training system,11,12
with five exceptions: (1) graders were certified to partici-
pate in fieldwork if they passed a slide-based test, rather
than an inter-grader agreement exercise using live sub-
jects; (2) we did not collect data on access to water and
sanitation; (3) examination was limited to 1–9-year-olds
and ≥50-year-olds, unlike other GTMP projects where all
consenting individuals aged ≥1 year living in sampled
households were examined; (4) a fixed number of chil-
dren (rather than a fixed number of households) was
recruited in each sampled cluster; and (5) for individuals
diagnosed with trichiasis, we asked questions about pre-
vious management of trichiasis through surgery or
epilation.
Individual-level demographic and examination data
were entered into the GTMP-LINKS application on
Android smartphones, transmitted to the Cloud, then
processed, and reviewed by VNIO (the agency desig-
nated by the Ministry of Health for oversight of
ophthalmic issues in Viet Nam), as described
elsewhere.12 Our principal outcome measures were the
evaluation unit (EU)-level TF prevalence in 1–9-year-
Table 1. Characteristics of survey population by evaluation unit, Global Trachoma Mapping Project, Viet Nam, 2014.
Province
Districts in evaluation
unit
Population
(2009)13
Evaluation
Unit Justification for survey
Vinh Phuc Vinh Tuong 189,000 1 Both districts had baseline prevalence of TF>10% in 2001 and both had
interventionsMe Linh 192,000
Yen Lac 145,000 2 Baseline (2001) <10% but 2005 MoH survey showed communes between 7.3–
13.5%Binh Xuyen 108,000
Lap Thach 118,000
Ha Tinh Can Loc 128,000 3 Both districts >10% in 2001 baseline and both had intervention
Nghi Xuan 98,000
Hoa Binh Kim Boi 114,000 4 Both districts >10% in 2001 baseline and both had intervention
Yen Thuy 60,000
Hung Yen Van Lam 113,000 5 District >10% in 2001 baseline and had intervention
Yen Bai Van Chan 144,000 6 Both districts >10% in 2001 baseline and both had intervention
Yen Bai town 91,000
Luc Yen 102,000 7 Baseline >10% but no intervention
Van Yen 27,000 2005 MoH >10% + intervention
Vinh Long Tam Binh 154,000 8 Baseline 9.5% and 10.1% but no intervention
Vung Liem 159,000
Hà Giang Bac Quang 45,000 9 2005 MoH survey of communes between 7.0–17.2%; intervention in 2 districts
Yen Minh 78,000
Bac Me 47,000
Ninh
Thuan
Ninh Hai 89,000 10 Baseline survey 5.3–5.8% in southern Viet Nam (intervention in one)
Ninh Phuoc 135,000
Binh
Thuan
Ham Tan 69,000 11 Baseline surveys 7.8–7.9%, no intervention
Tuy Phong 140,000
Bac Binh 117,000
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olds, and the EU-level prevalence of trichiasis unknown
to the health system in ≥50-year-olds.
We surveyed 11 EUs (covering 24 districts) selected
in consultation with programme partners. The full list
of EUs and the rationale for conducting a survey in
each one form Table 1.
Sample size calculations
We powered each survey to estimate the EU-level TF pre-
valence in 1–9-year-olds, using an expected prevalence of
10%, and aiming to have 95% confidence of estimating that
prevalence with absolute precision of ±3%. Our design
effect, based on previous surveys, was 2.65, which resulted
in a sample size estimate of 1019 children.12 We addition-
ally wished to estimate trichiasis prevalence in adults, but
our sample size was calculated only using parameters relat-
ing to TF in children.
Sample selection
Selection of clusters
We used two-stage cluster sampling, categorizing vil-
lages (thon) as our first-stage clusters. A list of thon in
each EU was obtained from the district authorities. We
systematically selected 20 thon with probability propor-
tional to population size, using a computer-generated
random starting point.
Selection of households and participants
In selected thon, we used compact segment sampling to
choose one segment (xom) at random. Within that
xom, a household was visited if at least one child aged
1–9 years, or at least one adult aged ≥50 years, lived
there (i.e., had slept there for the past month). If indi-
viduals in relevant age ranges were away from home
but were expected to be available later the same day, an
attempt was made to revisit the household. Once 60
children had been enrolled, the cluster was considered
complete. If 60 children could not be enrolled in a
single xom, the next-nearest xom was also visited.
Trachoma grading
Graders participating in the surveys had obtained a kappa
for diagnosing TF of ≥0.9 in an inter-grader agreement test
based on 50 conjunctival photographs of children with and
without active trachoma.11 Examination was undertaken
according to the criteria set out in the WHO simplified
trachoma grading scheme.13 Graders used binocular loupes
with 2.5× magnification, and the sun (or if necessary, a
torch) for illumination. When trichiasis was diagnosed in
an eye, the subject was asked if health workers had pre-
viously recommended surgery or epilation for that eye.
Data analysis
We conducted analyses in R (R Foundation for Statistical
Computing, Vienna, Austria) and Structured Query
Language. Cluster (xom)-level data on TF in1–9-year-olds
were adjusted for the age of those examined, using 1-year
age bands and the data from the most recent Viet Nam
census as the reference dataset.14 Similarly, cluster-level
data on trichiasis were adjusted for the age and gender of
those examined, using 5-year age bands and themost recent
census data.12 The EU-level prevalence of each sign was
calculated as the mean of the adjusted cluster-level propor-
tions.We calculated confidence intervals by bootstrapping,
with replacement, over 10,000 replications. Prevalence esti-
mates for trichiasis in those aged ≥50 years were used to
calculate estimates for the all-ages population by multiply-
ing the prevalence in ≥50-year-olds by 0.173: the propor-
tion of the national population aged≥50 years, based on the
2009 national census.14
Although we powered our surveys to estimate TF pre-
valence at EU level, our compact segment sampling
approach (involving examination of 60 consenting 1–9-
year-olds in a block of adjacent households in one or two
xom) means that the proportion of children with TF in a
cluster estimates the true prevalence for that group of
households. To visualize the distribution of TF by cluster
across the entire surveyed area, the means of the northings
and eastings for all householdswithin a cluster (obtained by
GPS) were calculated to provide a single set of coordinates;
results were plotted using QGIS (http://www.qgis.org/en/
site/). Using Mathematica 11.1 (Wolfram Research,
Champaign, IL, USA), we fit the cluster-level TF prevalence
data to a zero-inflated negative binomial, parametrized so
the mean of the distribution scaled with the sample size in
that community.
Ethical considerations
Ethical approval was granted by the ethics commit-
tees of the London School of Hygiene & Tropical
Medicine, London, UK (reference 6319) and the
Biomedical Ethics Board of National Institute of
Ophthalmology, Hanoi, Viet Nam. We obtained
informed verbal consent for examination from each
participant or (for children) from their parent or
guardian. Individuals with conjunctivitis, whether
meeting the definition of active trachoma or not,
were provided with two tubes of 1% tetracycline eye
ointment; individuals with trichiasis were referred to
a local surgeon.
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Results
Fieldwork was undertaken from May to August,
2014. In 9391 households, survey teams examined a
total of 20,185 residents (98.8% of those enumer-
ated), composed of 13,028 1–9-year-olds and
7,157 ≥ 50-year-olds. Table 2 summarizes the char-
acteristics of the population sampled by EU. Overall,
52% of 1–9-year-olds examined and 42% of ≥50-year-
olds examined were male. The mean ages of those
examined were 4.8 years (standard deviation 2.6) for
the 1–9-year-old group, and 63.4 years (10.4) for the
≥50-year-old group.
Prevalence of trachoma
The prevalence of TF in 1–9-year-olds was <5% in all
11 EUs and ranged from 0% to 1.6% (Table 3,
Figure 1). Among people aged ≥50 years, prevalence
of any trichiasis by EU ranged from 0% to 0.75%; these
estimates are equivalent to prevalences of any trichiasis
in all ages of 0–0.13%. Of 136 people identified as
having trichiasis, 125 (92%) were known to the health
system, meaning that management for eyes with tri-
chiasis had previously been (1) offered but refused; (2)
accepted and a surgical date set; or (3) received, but
disease had subsequently recurred. Accounting for
Table 2. Characteristics of survey population by evaluation unit, Global Trachoma Mapping Project, Viet Nam, 2014.
Province
Districts in evaluation
unit
Number of
households
surveyed
Children aged 1–9 years Adults aged ≥50 years
Number
enumerated
Proportion
examined (%)
Proportion
male (%)
Number
enumerated
Proportion
examined (%)
Proportion
male (%)
Vinh Phuc Yen Lac, Me Linh 595 1,206 97.4 52.8 758 99.5 41.8
Vinh Phuc Vinh Tuong, Binh
Xuyen, Lap Thach
573 1,211 99.8 51.5 748 100.0 44.1
Ha Tinh Can Loc, Nghi Xuan 846 1,212 98.2 52.6 482 98.8 37.1
Hoa Binh Kim Boi, Yen Thuy 910 1,193 99.3 53.6 317 100.0 35.3
Hung Yen Van Lam 905 1,218 98.3 54.2 1,192 99.3 41.9
Yen Bai Van Chan, Yen Bai
town
890 1,199 98.3 50.0 472 99.8 39.0
Yen Bai Luc Yen, Van Yen 867 1,208 99.7 53.6 417 98.1 42.0
Vinh Long Tam Binh, Vung Liem 1,342 1,214 98.9 48.6 1,609 99.9 42.3
Ha Giang Bac Quang, Yen Minh,
Bac Me
725 1,142 96.6 49.9 290 99.3 49.3
Ninh Thuan Ninh Hai, Ninh Phuoc 1,011 1,208 97.9 49.5 882 95.8 42.0
Binh Thuan Ham Tan, Tuy Phong,
Bac Binh
727 1,203 99.9 51.5 58 100.0 29.8
Total 9,391 13,214 98.6 51.6 7,225 99.1 41.6
Table 3. Prevalence of trachoma by evaluation unit, Global Trachoma Mapping Project, Viet Nam, 2014.
Province
Districts in
Evaluation Unit
Prevalence of TF in children
aged 1–9 years: % (95% CI)1
All trichiasis cases
Trichiasis cases unknown to health
system
Prevalence in adults
≥50 years: % (95% CI)2
Prevalence in
all ages: %3
Prevalence in adults
≥50 years: % (95% CI)2
Prevalence in
all ages: %3
Vinh Phuc Yen Lac, Me Linh 0 0.75 (0.41–1.15) 0.13 0.17 (0–0.39) 0.03
Vinh Phuc Vinh Tuong, Binh
Xuyen, Lap Thach
0.2 (0–0.5) 0.72 (0.49–1.02) 0.13 0.01 (0–0.04) 0.00
Ha Tinh Can Loc, Nghi Xuan 0.0 (0–0.1) 0.08 (0–0.21) 0.01 0 0.00
Hoa Binh Kim Boi, Yen Thuy 0 0.17 (0–0.41) 0.03 0 0.00
Hung Yen Van Lam 0 0.35 (0.14–0.58) 0.06 0.05 (0–0.12) 0.01
Yen Bai Van Chan, Yen Bai
town
0.1 (0–0.4) 0.22 (0.06–0.37) 0.04 0 0.00
Yen Bai Luc Yen, Van Yen 0.2 (0–0.7) 0.04 (0–0.10) 0.01 0 0.00
Vinh Long Tam Binh, Vung
Liem
0 0 0.00 0 0.00
Ha Giang Bac Quang, Yen
Minh, Bac Me
1.5 (0.5–2.9) 0.30 (0.05–0.57) 0.05 0 0.00
Ninh Thuan Ninh Hai, Ninh
Phuoc
0.1 (0–0.4) 0.45 (0.22 − 0.79) 0.08 0 0.00
Binh Thuan Ham Tan, Tuy
Phong, Bac Binh
0.2 (0–0.5) 0.23 (0.06–0.50) 0.04 0 0.00
CI, confidence interval.
1Adjusted for age, in one-year bands.
2Adjusted for gender and age, in five-year bands.
3The all-ages (population level) estimate was derived by multiplying the prevalence in ≥50-year-olds by 0.173: the proportion of the 2009 national population aged
≥50 years.
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previous management of trichiasis, the prevalence of
trichiasis unknown to the health system among people
aged ≥50 years, by EU, ranged from 0% to 0.17%,
which was equivalent to 0–0.03% in all ages (Table 3,
Figure 1).
Distribution of trichiasis by age, gender
The age- and gender-specific distribution of trichiasis
(in all EUs pooled together) is shown in Figure 2. The
age/gender-specific prevalence of trichiasis known to
the health system increased with age; however, there
were no statistically significant differences among males
compared to females (Figure 2(a)). There were very few
cases of trichiasis unknown to the health system
(Figure 2(b)).
Distribution of TF at cluster level
Of the 220 clusters surveyed, the proportion of 1–9-
year-olds with TF was 0% in 200 clusters; 1.6 to 3.5% in
19 clusters, and 10.3% in one cluster in Yên Minh
district of Hà Giang Province (Figure 3). Using max-
imum likelihood estimation, we calculated a shape
parameter for the negative binomial distribution of
0.17 (95% CI 0.07–388, bootstrap percentile, n = 999),
the very wide confidence intervals commensurate with
the fact that only 20 clusters contained cases of TF.
Discussion
This series of pre-validation trachoma surveillance sur-
veys showed that all 11 of the formerly endemic EUs
studied now have TF prevalence estimates below the
5% elimination threshold. While in two of 11 EUs, our
data suggest that the prevalence of trichiasis in all ages
was > 0.1% in 2014, most people with trichiasis appear
to be “known to the health system”. The prevalence of
trichiasis unknown to the health system in all ages was
below the elimination threshold in each EU.
These surveys were epidemiologically robust.
Whereas previous trachoma surveys in Viet Nam
used the assurance sampling trachoma rapid assess-
ment (ASTRA) methodology,15 we used PBPS meth-
ods recommended by WHO.12 Unlike ASTRA, PBPSs
provide point prevalence estimates for TF and
trichiasis,16 which are needed to determine if elim-
ination thresholds have been reached.9 A second
point of difference was the fact that individuals
with trichiasis were asked about previous manage-
ment recommendations from health workers: the
first GTMP-supported survey in which this was
Figure 1. Prevalence of (a) trachomatous inflammation—follicular (TF) in children aged 1–9 years and (b) trichiasis unknown to the
health system in all ages, Global Trachoma Mapping Project, Viet Nam, 2014.
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done. These questions were added in order to help
the country determine whether EUs had reached
elimination thresholds for trichiasis, which are
couched in terms of the prevalence of trichiasis
“unknown to the health system” – that is, the pre-
valence of trichiasis, counting only those individuals
with the condition who have not previously been
offered an operation or epilation for it.17 Following
successful implementation of the questions in Viet
Nam, their use was adopted throughout the GTMP.
There were some weaknesses in our work in Viet
Nam that should be acknowledged. Although we took
our methodological template from previous WHO
guidance18 and worked within the framework of the
GTMP,12 we did not examine individuals aged
10–49 years, in order to try to save time for our
fieldworkers, who went house-to-house to recruit sur-
vey subjects in steeply mountainous terrain. The rela-
tively small numbers of ≥50-year-olds examined in
each EU resulted in relatively wide confidence inter-
vals around the trichiasis prevalence estimates
(Table 3). The lack of examination of adults aged
<50 years potentially limits the comparison of our
findings to elimination targets, since in many tra-
choma-endemic settings, trichiasis can be seen in
people less than 50 years old. We have assumed that
the prevalence of trichiasis in people aged <50 years
was negligible. To a certain extent, this assumption is
supported by the age distribution of trichiasis cases
that the teams identified in the field (Figure 2), which
underpinned our transformation of the trichiasis pre-
valence estimates in ≥50-year-olds to all-ages esti-
mates. Our assessment of the trichiasis situation is
further limited by the fact that we did not record the
presence or absence of scars in the tarsal conjunctivae
of eyes noted to have trichiasis, because the recom-
mendation to do so was released after our surveys
were complete.19 However, this point may be moot
for Viet Nam, because the data at hand, allowing for
the limitations noted above, suggest that elimination
threshold prevalences for trichiasis have been
reached.
(A)
(B)
Figure 2. Age- and gender-specific prevalence of trichiasis (A) known, and (B) unknown to the health system in those aged
≥50 years; data from all evaluation units combined, Global Trachoma Mapping Project, Viet Nam, 2014.
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We also sought to trim fieldwork time by not col-
lecting household-level data on access to water and
sanitation, which was routinely integrated within tra-
choma surveys in other GTMP sub-projects.20–26 Due
to a paucity of cases of active trachoma, our graders did
not undertake live subject inter-grader agreement exer-
cises to qualify for survey deployment, but were instead
assessed using a standard set of 50 conjunctival photo-
graphs. During the GTMP, Lao PDR27 and Cambodia28
circumvented a similar lack of local cases by sending
trainee graders to Ethiopia for field training and certi-
fication, but this was not possible for Viet Nam. It is
possible that this lack of live-subject testing makes our
data less accurate. Finally, in most EUs, males were
relatively under-represented in the sample of ≥50-
year-olds examined (Table 2). This is a source of poten-
tial bias that would tend to lead to overestimation of
trichiasis prevalence (because trichiasis occurs more
frequently in women than in men)29; age- and gen-
der-based standardization will have partially, but not
completely, compensated. In all other respects, the
usual quality assurance and quality control measures
of the GTMP30 were deployed, and within the limita-
tions we have identified, we are confident of the
strength of the data we present here.31
Notwithstanding the wide confidence intervals for
the distribution shape parameter, the cluster-level dis-
tribution of TF cases was consistent with a geometric
distribution. We expect to see this pattern when an
infectious disease is disappearing32,33; it was not con-
sistent with a Poisson distribution. Occasional higher
prevalence communities are expected with a geometric
distribution. These do not necessarily represent persis-
tent outliers. Selecting a community in the tail of the
geometric distribution with a high prevalence is a pre-
dictable event. These outliers do not necessarily have
more transmission potential in the future, and may
regress towards the mean on future visits. While a
single cluster in Hà Giang Province had more than
one in 10 children with TF, it may not necessarily be
a focus of disease of public health significance.
Nonetheless, further investigations will be undertaken
in Hà Giang.
In the last few decades, Viet Nam has made huge
progress against trachoma. Momentum was accelerated
following national adoption of the SAFE strategy in the
late 1990s. From 2000 to 2008, 83,830 surgeries for tri-
chiasis were performed, more than 2.1 million azithro-
mycin (Zithromax®, Pfizer, New York, NY) treatments
were distributed to people in 850 endemic communes of
21 northern and central coastal provinces.34 The F and E
components of SAFE were also implemented.
Evaluations completed in 2004 and 2005 concluded that
(1) health promotion activities were excellent and imple-
mentation of water and sanitation improvement activities
were underway35 and (2) that F & E had significantly
contributed to reductions in the prevalence of active
trachoma.36 National-level estimates for 2015 suggested
Figure 3. Geographic distribution of cluster-level prevalence of TF in children aged 1–9 years, Global Trachoma Mapping Project,
Viet Nam, 2014.
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that 91% of households had access to drinking water
within a 30 minute round-trip, while 81% of households
had access to improved sanitation.37
The data presented here suggest that Viet Nam is
on track to meet GET2020 targets, and we recom-
mend that the country now starts populating a dos-
sier on trachoma’s elimination as a public health
problem.9 This dossier could serve as a valuable
information repository whilst further work is under-
taken to investigate (and, if necessary, manage) tra-
choma in Hà Giang and its surrounds. Members of
the WHO Alliance for GET2020 are ready and will-
ing to support.
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